Baird Medical Investment Holdings Limited cash flow to debt ratio of -6.96% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Baird Medical Investment Holdings Limited's free cash flow has increased -84.88% from $-9.17M last year to $-1.39M, signaling increasing performance

Baird Medical Investment Holdings Limited's debt to equity ratio is 0.62, which means that the company's assets are unhealthy financed, signaling financial risk.

Baird Medical Investment Holdings Limited's debt has increased relative to shareholder equity from 0.53 last year to 0.62 today, signaling weakened financials

Baird Medical Investment Holdings Limited has negative EBITDA, making leverage ratio unreliable

Baird Medical Investment Holdings Limited's interest coverage ratio is -34.75, which means that the company struggles to meet interest obligations, signaling financial risk.

Baird Medical Investment Holdings Limited's profit margin has decreased (459.97%) in the last year from 33.62% to -121.04%, signaling decreasing performance

Baird Medical Investment Holdings Limited's short-term assets of $54.97M exceed its short-term liabilities of $32.36M

Baird Medical Investment Holdings Limited's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Baird Medical Investment Holdings Limited's return on equity of -81.48%, is lower than 15.00%, indicating bad performance

Baird Medical Investment Holdings Limited's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Baird Medical Investment Holdings Limited has insufficient public price history to evaluate earnings stability.

Baird Medical Investment Holdings Limited has negative free cash flow, indicating the company is burning cash rather than generating it

Baird Medical Investment Holdings Limited has negative free cash flow, indicating cash burn

Baird Medical Investment Holdings Limited's yearly earnings has decreased 319.04% since last year from $12.45M to $-27.28M, signaling decreasing performance

Baird Medical Investment Holdings Limited's yearly revenue has decreased 39.15% since last year from $37.04M to $22.54M, signaling decreasing performance

ROIC -50.73% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Baird Medical Investment Holdings Limited's 3-year revenue CAGR of -13.72% is negative, indicating declining revenue over the past 3 years

Baird Medical Investment Holdings Limited had revenue growth in 3 out of 5 years, indicating consistent revenue performance

Baird Medical Investment Holdings Limited has insufficient public price history to evaluate ROE consistency.

Baird Medical Investment Holdings Limited has insufficient data to evaluate this check.

Baird Medical Investment Holdings Limited has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Baird Medical Investment Holdings Limited is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Baird Medical Investment Holdings Limited has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Baird Medical Investment Holdings Limited is undervalued relative to its fair value price of 4.74 based on Earnings Fair Value model

Baird Medical Investment Holdings Limited has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Baird Medical Investment Holdings Limited has a price-to-book ratio of 1.13x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Baird Medical Investment Holdings Limited has a price-to-sales ratio of 1.56x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue